Capital Analysts, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Capital Analysts, LLC

  • $2.45 Billion
  • Q3 2024

A detailed history of Capital Analysts, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Analysts, LLC holds 328 shares of REGN stock, worth $234,395. This represents 0.01% of its overall portfolio holdings.

Number of Shares
328
Previous 335 2.09%
Holding current value
$234,395
Previous $352,000 1.99%
% of portfolio
0.01%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $7,168 - $8,412
-7 Reduced 2.09%
328 $345,000
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $35,328 - $42,847
40 Added 13.56%
335 $352,000
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $902 - $993
1 Added 0.34%
295 $284,000
Q4 2023

Jan 30, 2024
SELL
$775.18 - $881.7 $775 - $881
-1 Reduced 0.34%
294 $258,000
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $8,309 - $10,132
12 Added 4.24%
295 $243,000
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $5,600 - $6,642
-8 Reduced 2.75%
283 $203,000
Q1 2023

May 05, 2023
SELL
$680.49 - $826.97 $15,651 - $19,020
-23 Reduced 7.32%
291 $239,000
Q4 2022

Feb 08, 2023
SELL
$705.89 - $766.39 $20,470 - $22,225
-29 Reduced 8.45%
314 $227,000
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $20,088 - $25,351
-35 Reduced 9.26%
343 $236,000
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $6,580 - $8,866
12 Added 3.28%
378 $223,000
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $57,726 - $67,747
-97 Reduced 20.95%
366 $256,000
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $9,239 - $11,406
17 Added 3.81%
463 $292,000
Q3 2021

Nov 04, 2021
BUY
$574.03 - $680.96 $26,405 - $31,324
46 Added 11.5%
446 $270,000
Q2 2021

Aug 05, 2021
SELL
$472.8 - $558.54 $945 - $1,117
-2 Reduced 0.5%
400 $223,000
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $12,061 - $14,801
27 Added 7.2%
402 $190,000
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $210,452 - $267,511
-440 Reduced 53.99%
375 $181,000
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $207,005 - $250,119
380 Added 87.36%
815 $456,000
Q2 2020

Aug 07, 2020
SELL
$493.32 - $643.92 $27,132 - $35,415
-55 Reduced 11.22%
435 $271,000
Q1 2020

May 08, 2020
BUY
$336.18 - $494.43 $18,489 - $27,193
55 Added 12.64%
490 $239,000
Q4 2019

Feb 12, 2020
BUY
$274.13 - $376.51 $119,246 - $163,781
435 New
435 $163,000

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email